Novel substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators
申请人:——
公开号:US20030073842A1
公开(公告)日:2003-04-17
The invention is directed to substituted benzimidazol-2-ones of Formula I,
1
wherein A, X, Y, m, n, R
1
, R
2
, R
3
, R
4
, and R
5
are as described in the specification, which are useful as vasopressin receptor antagonists or Neuropeptide Y Modulators for treating conditions such as aggression, obsessive-compulsive disorders, hypertension, dysmenorrhea, congestive heart failure/cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, edema, ischemia, stroke, thrombosis, water retention, nephrotic syndrome, central nervous injuries, obesity, anorexia, hyperglycemia, diabetes, anxiety, depression, asthma, memory loss, sexual dysfunction, disorders of sleep and other circadian rhythms, and Cushing's disease.
该发明涉及Formula I的取代苯并咪唑酮,其中A、X、Y、m、n、R1、R2、R3、R4和R5如说明书中所述,其可用作抗利尿素受体拮抗剂或神经肽Y调节剂,用于治疗侵略性、强迫症障碍、高血压、痛经、充血性心力衰竭/心脏不全、冠状动脉痉挛、心肌缺血、肝硬化、肾血管痉挛、肾功能衰竭、水肿、缺血、中风、血栓形成、水潴留、肾症候群、中枢神经损伤、肥胖、厌食、高血糖、糖尿病、焦虑、抑郁、哮喘、记忆丧失、性功能障碍、睡眠障碍和其他生物钟紊乱症状,以及库欣综合征。